Edgar Lomax Co. VA Cuts Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Edgar Lomax Co. VA trimmed its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 4.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,039,152 shares of the pharmacy operator's stock after selling 85,745 shares during the quarter. Walgreens Boots Alliance makes up 3.5% of Edgar Lomax Co. VA's investment portfolio, making the stock its 10th largest position. Edgar Lomax Co. VA owned approximately 0.24% of Walgreens Boots Alliance worth $53,242,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Assetmark Inc. grew its stake in shares of Walgreens Boots Alliance by 2,015.4% in the fourth quarter. Assetmark Inc. now owns 13,623 shares of the pharmacy operator's stock worth $356,000 after purchasing an additional 12,979 shares during the last quarter. CreativeOne Wealth LLC grew its position in shares of Walgreens Boots Alliance by 7.3% in the 4th quarter. CreativeOne Wealth LLC now owns 10,124 shares of the pharmacy operator's stock worth $264,000 after buying an additional 688 shares during the last quarter. Quest Partners LLC purchased a new position in shares of Walgreens Boots Alliance during the fourth quarter valued at approximately $30,000. Corient Private Wealth LLC raised its holdings in shares of Walgreens Boots Alliance by 38.9% during the fourth quarter. Corient Private Wealth LLC now owns 280,545 shares of the pharmacy operator's stock valued at $7,325,000 after acquiring an additional 78,523 shares in the last quarter. Finally, D.A. Davidson & CO. lifted its stake in Walgreens Boots Alliance by 6.3% in the fourth quarter. D.A. Davidson & CO. now owns 57,780 shares of the pharmacy operator's stock worth $1,509,000 after acquiring an additional 3,449 shares during the period. Institutional investors own 58.59% of the company's stock.

Insiders Place Their Bets

In other Walgreens Boots Alliance news, Director Inderpal S. Bhandari purchased 3,000 shares of the business's stock in a transaction on Thursday, April 11th. The stock was acquired at an average price of $18.05 per share, for a total transaction of $54,150.00. Following the purchase, the director now owns 3,000 shares of the company's stock, valued at approximately $54,150. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other Walgreens Boots Alliance news, Director Inderpal S. Bhandari purchased 3,000 shares of the company's stock in a transaction on Thursday, April 11th. The stock was acquired at an average cost of $18.05 per share, for a total transaction of $54,150.00. Following the purchase, the director now directly owns 3,000 shares of the company's stock, valued at approximately $54,150. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Manmohan Mahajan acquired 6,000 shares of Walgreens Boots Alliance stock in a transaction dated Tuesday, April 2nd. The shares were bought at an average price of $19.38 per share, for a total transaction of $116,280.00. Following the transaction, the chief financial officer now owns 166,969 shares of the company's stock, valued at $3,235,859.22. The disclosure for this purchase can be found here. 17.40% of the stock is owned by company insiders.

Walgreens Boots Alliance Stock Performance

Shares of NASDAQ:WBA traded down $1.14 during trading on Tuesday, hitting $16.68. The company's stock had a trading volume of 24,697,126 shares, compared to its average volume of 13,119,743. Walgreens Boots Alliance, Inc. has a 12 month low of $16.55 and a 12 month high of $32.89. The firm has a market cap of $14.39 billion, a price-to-earnings ratio of -2.38, a P/E/G ratio of 1.13 and a beta of 0.80. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.66 and a quick ratio of 0.32. The company has a 50-day moving average of $18.75 and a 200-day moving average of $21.27.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last posted its quarterly earnings data on Thursday, March 28th. The pharmacy operator reported $1.20 EPS for the quarter, topping the consensus estimate of $0.82 by $0.38. Walgreens Boots Alliance had a positive return on equity of 12.11% and a negative net margin of 4.18%. The firm had revenue of $37.05 billion during the quarter, compared to analyst estimates of $35.86 billion. During the same period in the prior year, the business posted $1.16 EPS. Walgreens Boots Alliance's revenue was up 6.3% on a year-over-year basis. On average, sell-side analysts expect that Walgreens Boots Alliance, Inc. will post 3.23 earnings per share for the current year.

Walgreens Boots Alliance Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, June 12th. Investors of record on Tuesday, May 21st will be issued a $0.25 dividend. This represents a $1.00 annualized dividend and a yield of 6.00%. The ex-dividend date of this dividend is Monday, May 20th. Walgreens Boots Alliance's dividend payout ratio is -14.29%.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on WBA. Deutsche Bank Aktiengesellschaft reduced their price objective on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set a "hold" rating on the stock in a research report on Wednesday, April 3rd. SVB Leerink lowered their price objective on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set a "market perform" rating for the company in a report on Monday, March 18th. HSBC reiterated a "reduce" rating and set a $20.00 target price (down previously from $27.00) on shares of Walgreens Boots Alliance in a report on Tuesday, February 20th. Bank of America dropped their price target on Walgreens Boots Alliance from $23.00 to $22.00 and set an "underperform" rating on the stock in a research report on Tuesday, March 26th. Finally, Truist Financial reissued a "hold" rating and set a $25.00 price objective on shares of Walgreens Boots Alliance in a research report on Monday, April 1st. Four equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have given a buy rating to the stock. According to MarketBeat, the company currently has an average rating of "Hold" and an average target price of $24.36.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.